Preclinical Models of Meningioma
- PMID: 37432629
- DOI: 10.1007/978-3-031-29750-2_15
Preclinical Models of Meningioma
Abstract
The management of clinically aggressive meningiomas remains challenging due to limited treatment options aside from surgical removal and radiotherapy. High recurrence rates and lack of effective systemic therapies contribute to the unfavorable prognosis of these patients. Accurate in vitro and in vivo models are critical for understanding meningioma pathogenesis and to identify and test novel therapeutics. In this chapter, we review cell models, genetically engineered mouse models, and xenograft mouse models, with special emphasis on the field of application. Finally, promising preclinical 3D models such as organotypic tumor slices and patient-derived tumor organoids are discussed.
Keywords: Anticancer drugs; Cell lines; Ex vivo; Heterotopic; Orthotopic; Preclinical; Xenograft.
© 2023. Springer Nature Switzerland AG.
References
-
- Baia GS, Slocum AL, Hyer JD, et al. A genetic strategy to overcome the senescence of primary meningioma cell cultures. J Neurooncol. 2006;78(2):113–121. doi: https://doi.org/10.1007/s11060-005-9076-y - DOI - PubMed
-
- Puduvalli VK, Li JT, Chen L, McCutcheon IE. Induction of Apoptosis in Primary Meningioma Cultures by Fenretinide. Cancer Res. 2005;65(4):1547–1553. doi: https://doi.org/10.1158/0008-5472.CAN-04-0786 - DOI - PubMed
-
- Greene HSN, Arnold H. The Homologous and Heterologous Transplantation of Brain and Brain Tumors. J Neurosurg. 1945;2(4):315–331. doi: https://doi.org/10.3171/jns.1945.2.4.0315 - DOI
-
- Klagsbrun M, Knighton D, Folkman J. Tumor angiogenesis activity in cells grown in tissue culture. Cancer Res. 1976;36(1):110–114. - PubMed
-
- Vogel HB, Berry RG. Chorioallantoic membrane heterotransplantation of human brain tumors. Int J Cancer. 1975;15(3):401–408. doi: https://doi.org/10.1002/ijc.2910150306 - DOI - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
